Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 1/20 | 0.41 |
| ▸ | IL23R | Q5VWK5 | 13/20 | 0.39 |
| ▸ | GLP1R | P43220 | 4/20 | 0.38 |
| ▸ | SCTR | P47872 | 1/20 | 0.38 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21766783 | 0.89 | SYK (0.47) | SYKIL23RGLP1RSCTR | |
| SCHEMBL30632044 | 0.77 | PTPN1 (0.39) | — | |
| SCHEMBL21766768 | 0.77 | PSMB5 (0.36) | IL23RGLP1RSCTR | |
| SCHEMBL21766737 | 0.74 | MAGI3 (0.39) | SYK | |
| SCHEMBL30788325 | 0.74 | BACE1 (0.38) | — | |
| SCHEMBL11134385 | 0.74 | GNPAT (0.47) | — | |
| SCHEMBL18676335 | 0.73 | CTSS (0.39) | — | |
| SCHEMBL18381304 | 0.72 | PTPN1 (0.39) | — | |
| SCHEMBL12873177 | 0.72 | CALCRL (0.37) | GLP1RSCTR | |
| SCHEMBL2742710 | 0.72 | CALCRL (0.37) | GLP1RSCTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10994017-B2 | Nerve labeling compositions and uses thereof | AVELAS BIOSCIENCES, INC. (US) | 2021-05-04 | — | — | US | disclosed |
| US-20200061200-A1 | NERVE LABELING COMPOSITIONS AND USES THEREOF | AVELAS ACQUISITION CORPORATION | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200061200-A1 | NERVE LABELING COMPOSITIONS AND USES THEREOF | GAP43, NGF, PMP22 | SYK 3247/4885IL23R 4181/4885GLP1R 2109/4885 |
| US-10994017-B2 | Nerve labeling compositions and uses thereof | GAP43, NGF, PMP22 | SYK 3247/4885IL23R 4181/4885GLP1R 2109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.